UBS Group’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-6,844
| Closed | -$2.53K | – | 9219 |
|
2023
Q3 | $2.53K | Sell |
6,844
-2,812
| -29% | -$1.04K | ﹤0.01% | 6537 |
|
2023
Q2 | $11.3K | Buy |
+9,656
| New | +$11.3K | ﹤0.01% | 6033 |
|
2023
Q1 | – | Sell |
-3,011
| Closed | -$9.58K | – | 10122 |
|
2022
Q4 | $9.58K | Buy |
3,011
+1,077
| +56% | +$3.43K | ﹤0.01% | 7441 |
|
2022
Q3 | $19K | Buy |
1,934
+1,755
| +980% | +$17.2K | ﹤0.01% | 6406 |
|
2022
Q2 | $6K | Buy |
+179
| New | +$6K | ﹤0.01% | 7776 |
|
2022
Q1 | – | Sell |
-133
| Closed | -$41K | – | 10191 |
|
2021
Q4 | $41K | Buy |
133
+87
| +189% | +$26.8K | ﹤0.01% | 6005 |
|
2021
Q3 | $36K | Buy |
+46
| New | +$36K | ﹤0.01% | 5491 |
|
2021
Q2 | – | Sell |
-8
| Closed | -$14K | – | 8925 |
|
2021
Q1 | $14K | Buy |
+8
| New | +$14K | ﹤0.01% | 6681 |
|
2020
Q4 | – | Sell |
-6
| Closed | -$22K | – | 7824 |
|
2020
Q3 | $22K | Buy |
6
+2
| +50% | +$7.33K | ﹤0.01% | 5391 |
|
2020
Q2 | $25K | Sell |
4
-6
| -60% | -$37.5K | ﹤0.01% | 5570 |
|
2020
Q1 | $33K | Hold |
10
| – | – | ﹤0.01% | 5259 |
|
2019
Q4 | $92K | Buy |
+10
| New | +$92K | ﹤0.01% | 5012 |
|